-1044-中华实验眼科杂志2020年12月第38卷第12期Chin J Exp Ophthalmol,December2020,Vol.38,No.12
+16,Gote V,Sidder S,Sicatte J,et a/Ocular drug de/vew：present innovations and future chClenges+J].J Pharmacol Exp Thes,2019, 370）3*：602—624.DOI：10.1124/jpeh119.256933.
+17]Wang X,Wang S,Zhang Y.Advance of the application of nano­controlled release system in ophthalmic drug delivew+J]•Drug Delia, 2016,23（8*：2897-2901.DOI：10.3109/10717544.2015.1116025.
+18]Vercauteren D,Rejrnan J,Martens TF,et al.On the cellular processing oonon-ei ea enanomedi cines oo enu ceei ca cid deeieeey：mechanismsand methods+J].J Control Release,2012,161（2*：566-581.DOI:10.
1016/j.jconreO2012.05.020.
+19]Amritc AC,KompeX a UB.Size-dependent disposition of nanoparticlcs and microparticles following subconjunctival administration+J].J Phaem Pha ema coe,2005,57（12*:1555-15633DOI：1031211L.pp3573 12300053
+20]Li J,Li Z,Zhou T,et al.Positively charged micelles based on a triblock copoWmes demonstrate enhanced carneal penetration+J].Lit J Nanomed/inc,2015,10:6027-6037.DOI：10.2147/IJN.S90347.
+21]周天洋，夏慧芸，何继军，等•15-羟基硬脂酸聚乙二醇酯胶束对盐酸特比萘芬滴眼液角膜吸收的促进作用+J]•中华实验眼科杂志, 2017,35（11*:1009-1013.DOI：10.3760/cma.j.imn.2095-0160.
201731130113
Zhou TY,Xia HY,He J,etae.Peomoting e o e cts oomaceogoe15 hydeoxysteaeate mice e s on coeneae absoeption oo teebinaoine hydrochloride+J].Chin J Exp Ophthalmol,2017,35（11*:1009-1013.
DOI：10.3760Lcma.issn.2095-0160.2017.11.011.
+22]De Campos AM,Sanchez A,Gref R,et a/The effect of a PEG versus a chitosan coatingon theinteeaction oFdeugco e o idaeca e i eeswith the ocular mucoso+J].Eus J Pharm Sei,2003,20（1*:73-81.DOI:10.
1016/s0928-0987（03*00178-7.
+23]Urt t i A,Pipkin J,Rork G,et a/Controlled drug delivew devices for experimental ocular studies with timolol  2.Ocular and systemic absorption in rabbits+ J].Int J Pharmaccut,1990,61（3*:241-249.
+24]Duoiraj C.Ocular pharmacokinetics+ J].Handb Exp Pharmacol, 2016, 242：31-55.DOI：10.1007/164_2016_32.
+25]Urt t i A.Cha/enges and obstacles of ocular pharmacokinetics and drug .6X^0+J]-Adv Drug Delio Rev,2006,58（11*:1131-1135.DOI：
10.1016/j.adds.2006.07.027.
（收稿日期:2020-05-26修回日期:2020-11-05*
（本文编辑：尹卫靖刘艳）
读者•作者•编者
眼科常用英文缩略语名词解释
AMD：年龄相关性黄斑变性（aye-related macular degeneration）ANOVA：单因素方差分析（one-way analysiz of variance*
BUT：泪膜破裂时间（breakup time of tear film*
DR：糖尿病视网膜病变（diabetic retinopathy*
EAU：实验性自身免疫性葡萄膜炎）expenmental autoimmune uveitis* EGF：表皮生长因子（epiderm
al growth factor*
ELISA：酶联免疫吸附测定（enzyme-linked immunosorbent assay* ERG：视网膜电图（OecWowPnovwm*
FFA：荧光素眼底血管造影（fundus tuoresccin angiography* FGF：成纤维细胞生长因子（fibroblast growth factor*
GFP：绿荧光蛋白（green tuoresccnt protein*
ITN-p：*干扰素（interferon-p*
IL：白细胞介素（interleukin*
IOL：人工晶状体（inWaocular Wns*
IRBP：光间受体视黄类物质结合蛋白（interphotoreccptor retinoid binding protein）
LASIK：准分子激光角膜原位磨镶术（laser W situ kewtomOeusis）ICGA：吲哚菁绿血管造影（indocyanine gw e n angiography* LECs：晶状体上皮细胞（Wns epithelial cells*
mi/NA：微小RNA（m/wRNA*
MMP：基质金属蛋白酶（matrin metalloproteinase*
mTOR：哺乳动物类雷帕霉素靶蛋白（mammalian target of rapamycin*MTT：四甲基偶氮唑盐（methyl thiazolyl tetrazolium*
odds
NF：核转录因子（nuclear factor*
OCT：光相干断层扫描（optical coherence tomography*
OR：优势比（odds rativ*
PACG：原发性闭角型青光眼（primao an/e-closuro glauccma* PCR：聚合酶链式反应（polymerase chain reaction*
RGCs：视网膜节细胞（retinal ganglion cells*
POAG：原发性开角型青光眼（primao open angle glauccma* RB：视网膜母细胞瘤（retinoblastoma*
RPE：视网膜素上皮（retinal pigment epithelium*
RNV：视网膜新生血管（retinal neevvscularization*
RP：视网膜素变性（retinitif pigmentosa*
S I W基础泪液分泌试验（Schirmer I test*
shRNA：小发夹RNA（short hairpin RNA*
siWNA：小干扰RNA（smal l inteWering RNA*
#-SMA：#-平滑肌肌动蛋白（a-rmooth muscle actin*
TAO：甲状腺相关眼病（thyroid-associated ophthalmopathy）TGF：转化生长因子（transforming growth factor*
TNF：肿瘤坏死因子（tumor necrosiz factor*
UBM：超声生物显微镜（ultrasound biomicrosccpe*
VEGF：血管内皮生长因子（vascular endothelial growth factor* VEP：视觉诱发电位（visual eveked potential*
（本刊编辑部）

版权声明：本站内容均来自互联网，仅供演示用，请勿用于商业和其他非法用途。如果侵犯了您的权益请与我们联系QQ:729038198，我们将在24小时内删除。